297 related articles for article (PubMed ID: 29606874)
1. Trastuzumab- and Fab' fragment-modified curcumin PEG-PLGA nanoparticles: preparation and evaluation in vitro and in vivo.
Duan D; Wang A; Ni L; Zhang L; Yan X; Jiang Y; Mu H; Wu Z; Sun K; Li Y
Int J Nanomedicine; 2018; 13():1831-1840. PubMed ID: 29606874
[TBL] [Abstract][Full Text] [Related]
2.
Huang C; Chen F; Zhang L; Yang Y; Yang X; Pan W
Int J Nanomedicine; 2020; 15():2987-2998. PubMed ID: 32431497
[TBL] [Abstract][Full Text] [Related]
3. Cyclic hexapeptide-conjugated nanoparticles enhance curcumin delivery to glioma tumor cells and tissue.
Zhang X; Li X; Hua H; Wang A; Liu W; Li Y; Fu F; Shi Y; Sun K
Int J Nanomedicine; 2017; 12():5717-5732. PubMed ID: 28848349
[TBL] [Abstract][Full Text] [Related]
4. Elaboration and characterization of curcumin-loaded Tri-CL-mPEG three-arm copolymeric nanoparticles by a microchannel technology.
Wu W; Wu J; Fu Q; Jin C; Guo F; Yan Q; Yang Q; Wu D; Yang Y; Yang G
Int J Nanomedicine; 2019; 14():4683-4695. PubMed ID: 31308653
[No Abstract] [Full Text] [Related]
5. Enhanced 4T1 breast carcinoma anticancer activity by co-delivery of doxorubicin and curcumin with core-shell drug-carrier based on heparin modified poly(L-lactide) grafted polyethylenimine cationic nanoparticles.
Guo O; Li X; Yang Y; Wei J; Zhao Q; Luo F; Qian Z
J Biomed Nanotechnol; 2014 Feb; 10(2):227-37. PubMed ID: 24738331
[TBL] [Abstract][Full Text] [Related]
6. Active targeting of block copolymer micelles with trastuzumab Fab fragments and nuclear localization signal leads to increased tumor uptake and nuclear localization in HER2-overexpressing xenografts.
Hoang B; Ekdawi SN; Reilly RM; Allen C
Mol Pharm; 2013 Nov; 10(11):4229-41. PubMed ID: 24066900
[TBL] [Abstract][Full Text] [Related]
7. Dual functional matrix metalloproteinase-responsive curcumin-loaded nanoparticles for tumor-targeted treatment.
Guo F; Fu Q; Jin C; Ji X; Yan Q; Yang Q; Wu D; Gao Y; Hong W; Li A; Yang G
Drug Deliv; 2019 Dec; 26(1):1027-1038. PubMed ID: 31691601
[TBL] [Abstract][Full Text] [Related]
8. Fab'-bearing siRNA TNFα-loaded nanoparticles targeted to colonic macrophages offer an effective therapy for experimental colitis.
Laroui H; Viennois E; Xiao B; Canup BS; Geem D; Denning TL; Merlin D
J Control Release; 2014 Jul; 186():41-53. PubMed ID: 24810114
[TBL] [Abstract][Full Text] [Related]
9. Preparation and in vivo pharmacokinetics of curcumin-loaded PCL-PEG-PCL triblock copolymeric nanoparticles.
Feng R; Song Z; Zhai G
Int J Nanomedicine; 2012; 7():4089-98. PubMed ID: 22888245
[TBL] [Abstract][Full Text] [Related]
10. Curcumin-Loaded Hybrid Nanoparticles: Microchannel-Based Preparation and Antitumor Activity in a Mouse Model.
Hong W; Gao Y; Lou B; Ying S; Wu W; Ji X; Yu N; Jiao Y; Wang H; Zhou X; Li A; Guo F; Yang G
Int J Nanomedicine; 2021; 16():4147-4159. PubMed ID: 34168445
[TBL] [Abstract][Full Text] [Related]
11. Co-delivery of docetaxel and curcumin prodrug via dual-targeted nanoparticles with synergistic antitumor activity against prostate cancer.
Yan J; Wang Y; Jia Y; Liu S; Tian C; Pan W; Liu X; Wang H
Biomed Pharmacother; 2017 Apr; 88():374-383. PubMed ID: 28122302
[TBL] [Abstract][Full Text] [Related]
12. Targeted delivery of polyamidoamine-paclitaxel conjugate functionalized with anti-human epidermal growth factor receptor 2 trastuzumab.
Ma P; Zhang X; Ni L; Li J; Zhang F; Wang Z; Lian S; Sun K
Int J Nanomedicine; 2015; 10():2173-90. PubMed ID: 25834432
[TBL] [Abstract][Full Text] [Related]
13. A Novel Folic Acid Receptor-Targeted Drug Delivery System Based on Curcumin-Loaded β-Cyclodextrin Nanoparticles for Cancer Treatment.
Hong W; Guo F; Yu N; Ying S; Lou B; Wu J; Gao Y; Ji X; Wang H; Li A; Wang G; Yang G
Drug Des Devel Ther; 2021; 15():2843-2855. PubMed ID: 34234415
[TBL] [Abstract][Full Text] [Related]
14. Odorranalectin modified PEG-PLGA/PEG-PBLG curcumin-loaded nanoparticle for intranasal administration.
Li X; Su J; Kamal Z; Guo P; Wu X; Lu L; Wu H; Qiu M
Drug Dev Ind Pharm; 2020 Jun; 46(6):899-909. PubMed ID: 32375569
[TBL] [Abstract][Full Text] [Related]
15. Preparation and characterization of PE38KDEL-loaded anti-HER2 nanoparticles for targeted cancer therapy.
Chen H; Gao J; Lu Y; Kou G; Zhang H; Fan L; Sun Z; Guo Y; Zhong Y
J Control Release; 2008 Jun; 128(3):209-16. PubMed ID: 18450313
[TBL] [Abstract][Full Text] [Related]
16. Epithelial cell adhesion molecule aptamer functionalized PLGA-lecithin-curcumin-PEG nanoparticles for targeted drug delivery to human colorectal adenocarcinoma cells.
Li L; Xiang D; Shigdar S; Yang W; Li Q; Lin J; Liu K; Duan W
Int J Nanomedicine; 2014; 9():1083-96. PubMed ID: 24591829
[TBL] [Abstract][Full Text] [Related]
17. Trastuzumab-modified DM1-loaded nanoparticles for HER2
Rong L; Zhou S; Liu X; Li A; Jing T; Liu X; Zhang Y; Cai S; Tang X
Artif Cells Nanomed Biotechnol; 2018 Dec; 46(8):1708-1718. PubMed ID: 29069935
[TBL] [Abstract][Full Text] [Related]
18. Co-delivery of doxorubicin and pH-sensitive curcumin prodrug by transferrin-targeted nanoparticles for breast cancer treatment.
Cui T; Zhang S; Sun H
Oncol Rep; 2017 Feb; 37(2):1253-1260. PubMed ID: 28075466
[TBL] [Abstract][Full Text] [Related]
19. PEGylated self-assembled enzyme-responsive nanoparticles for effective targeted therapy against lung tumors.
Guo F; Wu J; Wu W; Huang D; Yan Q; Yang Q; Gao Y; Yang G
J Nanobiotechnology; 2018 Jul; 16(1):57. PubMed ID: 30012166
[TBL] [Abstract][Full Text] [Related]
20. Anti-Human Epidermal Growth Factor Receptor 2 Single-Chain Fv Fragment-Decorated DM1 Nanoparticles for Specific Targeting of Human Epidermal Growth Factor Receptor 2-Positive Breast Tumor Cells.
Ni L; Li YX
J Biomed Nanotechnol; 2021 Mar; 17(3):447-455. PubMed ID: 33875079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
